English
简体中文
Total: £ 56.28
Published Date: 2024-11-19 | Pages: 109 | Tables: 177 | Medical Care
The global market for Respiratory Viruses Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Viruses Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Viruses Tests by region & country, by Type, and by Application.
The Respiratory Viruses Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Viruses Tests.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
QIAGEN International
Lonza
Wuxi Pharmatech (Cayman)
Merck
Eurofins Scientific
Danaher
Bio-Rad Laboratories
Novogene Corporation
Sartorius
Segment by Type:
Rhinovirus
Respiratory syncytial virus
Influenza A/B
All Coronaviruses
Others
Segment by Application
Laboratory
Hospital
Academic Institute
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Viruses Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Respiratory Viruses Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Respiratory Viruses Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Respiratory Viruses Tests Product Introduction
1.2 Global Respiratory Viruses Tests Market Size Forecast
1.3 Respiratory Viruses Tests Market Trends & Drivers
1.3.1 Respiratory Viruses Tests Industry Trends
1.3.2 Respiratory Viruses Tests Market Drivers & Opportunity
1.3.3 Respiratory Viruses Tests Market Challenges
1.3.4 Respiratory Viruses Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Respiratory Viruses Tests Players Revenue Ranking (2023)
2.2 Global Respiratory Viruses Tests Revenue by Company (2019-2024)
2.3 Key Companies Respiratory Viruses Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies Respiratory Viruses Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of Respiratory Viruses Tests
2.6 Respiratory Viruses Tests Market Competitive Analysis
2.6.1 Respiratory Viruses Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Respiratory Viruses Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Viruses Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rhinovirus
3.1.2 Respiratory syncytial virus
3.1.3 Influenza A/B
3.1.4 All Coronaviruses
3.1.5 Others
3.2 Global Respiratory Viruses Tests Sales Value by Type
3.2.1 Global Respiratory Viruses Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Respiratory Viruses Tests Sales Value, by Type (2019-2030)
3.2.3 Global Respiratory Viruses Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Hospital
4.1.3 Academic Institute
4.2 Global Respiratory Viruses Tests Sales Value by Application
4.2.1 Global Respiratory Viruses Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Respiratory Viruses Tests Sales Value, by Application (2019-2030)
4.2.3 Global Respiratory Viruses Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Respiratory Viruses Tests Sales Value by Region
5.1.1 Global Respiratory Viruses Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Respiratory Viruses Tests Sales Value by Region (2019-2024)
5.1.3 Global Respiratory Viruses Tests Sales Value by Region (2025-2030)
5.1.4 Global Respiratory Viruses Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Respiratory Viruses Tests Sales Value, 2019-2030
5.2.2 North America Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Respiratory Viruses Tests Sales Value, 2019-2030
5.3.2 Europe Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Respiratory Viruses Tests Sales Value, 2019-2030
5.4.2 Asia Pacific Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Respiratory Viruses Tests Sales Value, 2019-2030
5.5.2 South America Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Respiratory Viruses Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Respiratory Viruses Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Respiratory Viruses Tests Sales Value
6.3 United States
6.3.1 United States Respiratory Viruses Tests Sales Value, 2019-2030
6.3.2 United States Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Respiratory Viruses Tests Sales Value, 2019-2030
6.4.2 Europe Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Respiratory Viruses Tests Sales Value, 2019-2030
6.5.2 China Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Respiratory Viruses Tests Sales Value, 2019-2030
6.6.2 Japan Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Respiratory Viruses Tests Sales Value, 2019-2030
6.7.2 South Korea Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Respiratory Viruses Tests Sales Value, 2019-2030
6.8.2 Southeast Asia Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Respiratory Viruses Tests Sales Value, 2019-2030
6.9.2 India Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India Respiratory Viruses Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Respiratory Viruses Tests Products, Services and Solutions
7.1.4 Roche Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Respiratory Viruses Tests Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 QIAGEN International
7.3.1 QIAGEN International Profile
7.3.2 QIAGEN International Main Business
7.3.3 QIAGEN International Respiratory Viruses Tests Products, Services and Solutions
7.3.4 QIAGEN International Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Lonza Recent Developments
7.4 Lonza
7.4.1 Lonza Profile
7.4.2 Lonza Main Business
7.4.3 Lonza Respiratory Viruses Tests Products, Services and Solutions
7.4.4 Lonza Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Lonza Recent Developments
7.5 Wuxi Pharmatech (Cayman)
7.5.1 Wuxi Pharmatech (Cayman) Profile
7.5.2 Wuxi Pharmatech (Cayman) Main Business
7.5.3 Wuxi Pharmatech (Cayman) Respiratory Viruses Tests Products, Services and Solutions
7.5.4 Wuxi Pharmatech (Cayman) Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Wuxi Pharmatech (Cayman) Recent Developments
7.6 Merck
7.6.1 Merck Profile
7.6.2 Merck Main Business
7.6.3 Merck Respiratory Viruses Tests Products, Services and Solutions
7.6.4 Merck Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.6.5 Merck Recent Developments
7.7 Eurofins Scientific
7.7.1 Eurofins Scientific Profile
7.7.2 Eurofins Scientific Main Business
7.7.3 Eurofins Scientific Respiratory Viruses Tests Products, Services and Solutions
7.7.4 Eurofins Scientific Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Eurofins Scientific Recent Developments
7.8 Danaher
7.8.1 Danaher Profile
7.8.2 Danaher Main Business
7.8.3 Danaher Respiratory Viruses Tests Products, Services and Solutions
7.8.4 Danaher Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.8.5 Danaher Recent Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Profile
7.9.2 Bio-Rad Laboratories Main Business
7.9.3 Bio-Rad Laboratories Respiratory Viruses Tests Products, Services and Solutions
7.9.4 Bio-Rad Laboratories Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.9.5 Bio-Rad Laboratories Recent Developments
7.10 Novogene Corporation
7.10.1 Novogene Corporation Profile
7.10.2 Novogene Corporation Main Business
7.10.3 Novogene Corporation Respiratory Viruses Tests Products, Services and Solutions
7.10.4 Novogene Corporation Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.10.5 Novogene Corporation Recent Developments
7.11 Sartorius
7.11.1 Sartorius Profile
7.11.2 Sartorius Main Business
7.11.3 Sartorius Respiratory Viruses Tests Products, Services and Solutions
7.11.4 Sartorius Respiratory Viruses Tests Revenue (US$ Million) & (2019-2024)
7.11.5 Sartorius Recent Developments
8 Industry Chain Analysis
8.1 Respiratory Viruses Tests Industrial Chain
8.2 Respiratory Viruses Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Respiratory Viruses Tests Sales Model
8.5.2 Sales Channel
8.5.3 Respiratory Viruses Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Respiratory Viruses Tests Market Trends
Table 2. Respiratory Viruses Tests Market Drivers & Opportunity
Table 3. Respiratory Viruses Tests Market Challenges
Table 4. Respiratory Viruses Tests Market Restraints
Table 5. Global Respiratory Viruses Tests Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Respiratory Viruses Tests Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Respiratory Viruses Tests Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Respiratory Viruses Tests Product Type
Table 9. Key Companies Time to Begin Mass Production of Respiratory Viruses Tests
Table 10. Global Respiratory Viruses Tests Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Viruses Tests as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Respiratory Viruses Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Respiratory Viruses Tests Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Respiratory Viruses Tests Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Respiratory Viruses Tests Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Respiratory Viruses Tests Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Respiratory Viruses Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Respiratory Viruses Tests Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Respiratory Viruses Tests Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Respiratory Viruses Tests Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Respiratory Viruses Tests Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Respiratory Viruses Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Respiratory Viruses Tests Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Respiratory Viruses Tests Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Respiratory Viruses Tests Sales Value by Region (2019-2024) & (%)
Table 27. Global Respiratory Viruses Tests Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Respiratory Viruses Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Respiratory Viruses Tests Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Respiratory Viruses Tests Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Respiratory Viruses Tests Products, Services and Solutions
Table 34. Revenue (US$ Million) in Respiratory Viruses Tests Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Respiratory Viruses Tests Products, Services and Solutions
Table 39. Revenue (US$ Million) in Respiratory Viruses Tests Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. QIAGEN International Basic Information List
Table 42. QIAGEN International Description and Business Overview
Table 43. QIAGEN International Respiratory Viruses Tests Products, Services and Solutions
Table 44. Revenue (US$ Million) in Respiratory Viruses Tests Business of QIAGEN International (2019-2024)
Table 45. QIAGEN International Recent Developments
Table 46. Lonza Basic Information List
Table 47. Lonza Description and Business Overview
Table 48. Lonza Respiratory Viruses Tests Products, Services and Solutions
Table 49. Revenue (US$ Million) in Respiratory Viruses Tests Business of Lonza (2019-2024)
Table 50. Lonza Recent Developments
Table 51. Wuxi Pharmatech (Cayman) Basic Information List
Table 52. Wuxi Pharmatech (Cayman) Description and Business Overview
Table 53. Wuxi Pharmatech (Cayman) Respiratory Viruses Tests Products, Services and Solutions
Table 54. Revenue (US$ Million) in Respiratory Viruses Tests Business of Wuxi Pharmatech (Cayman) (2019-2024)
Table 55. Wuxi Pharmatech (Cayman) Recent Developments
Table 56. Merck Basic Information List
Table 57. Merck Description and Business Overview
Table 58. Merck Respiratory Viruses Tests Products, Services and Solutions
Table 59. Revenue (US$ Million) in Respiratory Viruses Tests Business of Merck (2019-2024)
Table 60. Merck Recent Developments
Table 61. Eurofins Scientific Basic Information List
Table 62. Eurofins Scientific Description and Business Overview
Table 63. Eurofins Scientific Respiratory Viruses Tests Products, Services and Solutions
Table 64. Revenue (US$ Million) in Respiratory Viruses Tests Business of Eurofins Scientific (2019-2024)
Table 65. Eurofins Scientific Recent Developments
Table 66. Danaher Basic Information List
Table 67. Danaher Description and Business Overview
Table 68. Danaher Respiratory Viruses Tests Products, Services and Solutions
Table 69. Revenue (US$ Million) in Respiratory Viruses Tests Business of Danaher (2019-2024)
Table 70. Danaher Recent Developments
Table 71. Bio-Rad Laboratories Basic Information List
Table 72. Bio-Rad Laboratories Description and Business Overview
Table 73. Bio-Rad Laboratories Respiratory Viruses Tests Products, Services and Solutions
Table 74. Revenue (US$ Million) in Respiratory Viruses Tests Business of Bio-Rad Laboratories (2019-2024)
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Novogene Corporation Basic Information List
Table 77. Novogene Corporation Description and Business Overview
Table 78. Novogene Corporation Respiratory Viruses Tests Products, Services and Solutions
Table 79. Revenue (US$ Million) in Respiratory Viruses Tests Business of Novogene Corporation (2019-2024)
Table 80. Novogene Corporation Recent Developments
Table 81. Sartorius Basic Information List
Table 82. Sartorius Description and Business Overview
Table 83. Sartorius Respiratory Viruses Tests Products, Services and Solutions
Table 84. Revenue (US$ Million) in Respiratory Viruses Tests Business of Sartorius (2019-2024)
Table 85. Sartorius Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Respiratory Viruses Tests Downstream Customers
Table 89. Respiratory Viruses Tests Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Respiratory Viruses Tests Product Picture
Figure 2. Global Respiratory Viruses Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 4. Respiratory Viruses Tests Report Years Considered
Figure 5. Global Respiratory Viruses Tests Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Viruses Tests Revenue in 2023
Figure 7. Respiratory Viruses Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rhinovirus Picture
Figure 9. Respiratory syncytial virus Picture
Figure 10. Influenza A/B Picture
Figure 11. All Coronaviruses Picture
Figure 12. Others Picture
Figure 13. Global Respiratory Viruses Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Respiratory Viruses Tests Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Laboratory
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Academic Institute
Figure 18. Global Respiratory Viruses Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Respiratory Viruses Tests Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Respiratory Viruses Tests Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Respiratory Viruses Tests Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Respiratory Viruses Tests Sales Value (%), (2019-2030)
Figure 31. United States Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 37. China Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 39. China Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 49. India Respiratory Viruses Tests Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Respiratory Viruses Tests Sales Value by Type (%), 2023 VS 2030
Figure 51. India Respiratory Viruses Tests Sales Value by Application (%), 2023 VS 2030
Figure 52. Respiratory Viruses Tests Industrial Chain
Figure 53. Respiratory Viruses Tests Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
